Rezolute, Inc.: Invus Global Management, LLC discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Invus Global Management, LLC disclosed a stake exceeding 5% in Rezolute, Inc. via a Schedule 13G filing with the SEC (accession 0002005369-26-000064). The filing signals that Invus has crossed the 5% beneficial ownership threshold, making it a reportable major shareholder in the clinical-stage biopharmaceutical company. The exact share count and percentage were not specified in the headline disclosure. Investors will watch for further detail in the full filing and any subsequent 13G amendments that clarify Invus's position size and intent.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Invus Global Management, LLC, Rezolute, Inc.